alexa Using Brain Imaging To Identify New Targets And Strategies For Addiction Treatment | 18017
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Share This Page

Using brain imaging to identify new targets and strategies for addiction treatment

3rd International Conference and Exhibition on Addiction Research & Therapy

Kelvin Lim

Keynote: J Addict Res Ther

DOI: 10.4172/2155-6105.S1.014

Abstract
T reatment outcome for addiction is dismal; about 64% of those entering treatment will relapse within one year after treatment. Of those 36% able to maintain abstinence for a year, only 66% will go on to remain abstinent for 3 years (cumulative 24%). The good news is that those who make it beyond 3 years of abstinence have an 86% chance of remaining abstinent. Data collected in our laboratory in abstinent users has identified brain patterns that can predict their future relapse. These brain patterns provide possible novel approaches for relapse prevention and improved treatment outcome
Biography
Kelvin Lim received his MD from Johns Hopkins University and completed a psychiatry residency and neuroimaging fellowship at Stanford University. Since 2001, he has held the Drs. T.J. and Ellla M. Arneson Land Grant Chair in Human Behavior in the Department of Psychiatry at the University of Minnesota. His research interests are in the use of neuroimaging methods to inform the diagnosis, prognosis and treatment of psychiatric disorders including addiction and schizophrenia. He has received research funding from the NIH and Department of Veterans Affairs.
Top